Anyra 40 mg/ml Injection contains the active constituent Aflibercept. Anyra. It is used to treat eye conditions in which impaired vision occurs due to the formation of an abnormal blood vessel inside the eye. These include wet age-related macular degeneration and diabetic macular edema. In studies, this medication effectively reduces the risk of vision loss and improves visual acuity in people with these conditions. Most patients generally well-tolerated it, and the injection procedure is relatively quick and minimally invasive.

You should avoid this medication, Anyra 40mg/ml Injection, if you have severe hypersensitivity reactions to other anti-VEGF medications. Tell your physician if a person has glaucoma, a history of seeing floaters or flashes, and other illnesses before taking Anyra 40mg/ml Injection. It will not be given if you have an infection or inflammation around the eye. Tell your doctor if surgery was performed recently or planned on your eye before taking this medication.

• Neovascular (wet) age-related macular degeneration (wet AMD)

• Diabetic macular edema (DME)

• Myopic choroidal neovascularization (myopic CNV)

• Macular edema secondary to retinal vein occlusion

Anyra 40 mg/ml injection works by binding to and blocking the activity of vascular endothelial growth factor (VEGF). This protein can cause abnormal blood vessel growth and leakage in the eye, leading to vision loss. By inhibiting the activity of VEGF, this medication can help reduce abnormal blood vessel growth and leakage and improve vision in some people with these eye conditions.

A healthcare provider will inject the Anyra 40 mg/ml injection around the eye in a clinical setting. The dosage and frequency of infusions will vary depending on the patient's medical condition, age, weight, and other factors. A person should not take a double dose to make up the second dose.

Serious:

• Blood clots or stroke

• Heart attack

• Severe bleeding or hemorrhage

• Gastrointestinal perforation (a hole in the stomach or intestine)

• Severe infections

• Hypertensive crisis (a sudden and severe increase in blood pressure)

Common:

• Eye pain, irritation, or redness

• Blurred vision

• Increased tear production

• Sensitivity to light

• Headache

• High blood pressure

• Nasal congestion

• Nausea

• Vomiting

• Diarrhea

• Back pain

• Joint pain

Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with the Anyra 40 mg/ml injection and reduce effectiveness by causing undesirable side effects.

• Store in a refrigerator at 2-8°C.

• Do not freeze.

• Protected from light.

• Keep it in its original packaging until it is ready to be used.

• Keep out of the reach of children and pets.

• Should be disposed of properly.

If you are currently being treated with Aflibercept, it is crucial to notify your healthcare provider immediately if you feel any side effects or have any concerns. For pregnant individuals planning to conceive or breastfeeding, it is essential to consult with your healthcare provider to discuss the potential risks and benefits associated with the treatment. Patients with diabetic retinopathy should be closely monitored during treatment because this medication can worsen the condition.

If you experience symptoms such as eye pain, worsening redness of the eye, reduced or blurry vision, or increased sensitivity to light while undergoing treatment, inform your doctor promptly. Lifestyle changes, including quitting smoking, maintaining a healthy weight, and following a healthy diet, can improve overall health and reduce the risk of cancer-related complications. Emotional support from family, friends, or support groups can help cancer patients manage their treatment challenges.